Header
Register
Stage IA Uterine Papillary Serous Carcinoma Treatment Calculator
Calculate your score Read the paper

What does this calculator do?

Based on demographic and surgical characteristics from hundreds of patients, we calculate a clinical score to determine if chemotherapy would be beneficial for you in treating Stage IA UPSC.

How does this calculator work?

The results come from a machine learning model based on NCDB data of 1,751 patients between the years 2010 to 2014. The 5-year survival rates and risk categories mentioned below are based on these patients.

The calculator produces a score based on the answers to the questions below.

What do the risk categories mean?

  • Low risk:

    A score less than 11 means that a patient falls into the "low risk" category. For low risk patients in the study, chemotherapy increases the 5-year survival from 84% to 87%.

  • Moderate risk:

    Patients who score between 11 and 16 fall into the "moderate risk" category and may benefit from chemotherapy. For moderate risk patients in the study, chemotherapy increases the 5-year survival from 66% to 79%.

  • High risk:

    Patients who score 16 or higher are in the "high risk" group and may benefit from chemotherapy. For high risk patients in the study, chemotherapy increases the 5-year survival from 42% to 64%.

DISCLAIMER: this risk calculator estimates the chance of a favorable outcome from chemotherapy. This chance is calculated based on information provided below and data from a large number of patients with similar information. Please note the chance of a favorable outcome is only an estimate and there may be other important factors not included in the calculator. Results are not guaranteed. Please consult a doctor about these results. Jinfiniti is not responsible for medical decisions made based on the results of this calculator.

Enter your information:

1. Do you have lymphovascular space invasion?
More info
Lymphovascular space invasion (LVSI) is the presence of tumor cells inside of the capillary lumens of either the lymphatic or microvascular drainage systems within the primary tumor. Cancers with LVSI are more likely to spread to other parts of the body.
3. Do you have or have you had any of the following conditions? (select all that apply).
  • Mild liver disease includes chronic hepatitis or cirrhosis without portal hypertension
  • Complications include renal, heart, eye, or neuropathy that are a result of your diabetes
  • Severe liver disease would include cirrhosis and portal hypertension with variceal bleeding history
  • Moderate liver disease would include cirrhosis and portal hypertension without variceal bleeding history
More info
The CDCC is a number that adds up your health problems such as heart failure or diabetes. These health problems are called comorbities. Cancer treatments can have bad side effects because of comorbities, so oncologists consider treatments that minimize the risk of these side effects. Click here for more information.
More info
This is the length of the longest part of your tumor measured in centimeters.
5. Have you had a pelvic lymph node dissection?
6. Have you had a paraaortic lymph node dissection?
7. Have you had an omentectomy?
More info
The CDCC is a number that adds up your health problems such as heart failure or diabetes. These health problems are called comorbities. Cancer treatments can have bad side effects because of comorbities, so oncologists consider treatments that minimize the risk of these side effects. Click here for more information.